On February 18, 2011
Where the Drugs Are: The Best and Worst Pharma R&D Pipelines
Novartis has the biggest pipeline in terms of estimated future revenues of nine large pharmaceutical companies, and Eli Lilly has the worst, according to an investors’ note.
No tags for this post.
0 Comments